DK1423109T3 - Præparater som omfatter pektin og ascorbinsyre - Google Patents

Præparater som omfatter pektin og ascorbinsyre

Info

Publication number
DK1423109T3
DK1423109T3 DK02774534T DK02774534T DK1423109T3 DK 1423109 T3 DK1423109 T3 DK 1423109T3 DK 02774534 T DK02774534 T DK 02774534T DK 02774534 T DK02774534 T DK 02774534T DK 1423109 T3 DK1423109 T3 DK 1423109T3
Authority
DK
Denmark
Prior art keywords
compositions
ascorbic acid
pectin
kdalton
compressible
Prior art date
Application number
DK02774534T
Other languages
Danish (da)
English (en)
Inventor
Chyi-Cheng Chen
Bruno Leuenberger
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of DK1423109T3 publication Critical patent/DK1423109T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK02774534T 2001-09-03 2002-08-24 Præparater som omfatter pektin og ascorbinsyre DK1423109T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01121067 2001-09-03

Publications (1)

Publication Number Publication Date
DK1423109T3 true DK1423109T3 (da) 2005-12-27

Family

ID=8178509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02774534T DK1423109T3 (da) 2001-09-03 2002-08-24 Præparater som omfatter pektin og ascorbinsyre

Country Status (13)

Country Link
US (2) US20050008692A1 (https=)
EP (1) EP1423109B1 (https=)
JP (1) JP4339685B2 (https=)
KR (1) KR100628603B1 (https=)
CN (2) CN101653421A (https=)
AT (1) ATE307579T1 (https=)
BR (1) BRPI0212195B8 (https=)
CA (1) CA2458209C (https=)
DE (1) DE60206940T2 (https=)
DK (1) DK1423109T3 (https=)
ES (1) ES2250711T3 (https=)
MX (1) MXPA04001768A (https=)
WO (1) WO2003020265A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
RU2246936C1 (ru) * 2003-05-19 2005-02-27 Открытое акционерное общество "Концерн Стирол" Витаминная композиция
ATE480233T1 (de) * 2005-02-15 2010-09-15 Dsm Ip Assets Bv Zusammensetzungen mit polysacchariden
CN101074270B (zh) * 2006-05-17 2010-09-22 烟台安德利果胶有限公司 高分子苹果果胶的生产工艺
WO2009056212A1 (en) * 2007-10-29 2009-05-07 Dsm Ip Assets B.V. Compositions containing resveratrol and pectin
WO2009152321A1 (en) * 2008-06-11 2009-12-17 The Curators Of The University Of Missouri Liquid chromatography detector and flow controller therefor
JP5975453B2 (ja) * 2008-11-14 2016-08-23 株式会社 アスキー 多糖類の抽出方法
CZ302789B6 (cs) 2009-11-25 2011-11-09 Zentiva, K. S. Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312594A (en) 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
US3453368A (en) 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
US3490742A (en) 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3459863A (en) 1966-10-14 1969-08-05 Merck & Co Inc Color-stable ascorbic acid tablet
US3615591A (en) 1968-10-21 1971-10-26 Pet Inc Method of making a peanut butter - jelly product
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
FR2036890B1 (https=) 1969-04-15 1973-01-12 Orsymonde
US3946110A (en) 1974-05-30 1976-03-23 Peter, Strong Research And Development Company, Inc. Medicinal compositions and methods of preparing the same
US4225628A (en) 1979-04-30 1980-09-30 Ben Hill Griffin, Inc. Citrus fiber additive product and process for making same
JPS5759803A (en) 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
DE3209630A1 (de) 1982-03-17 1983-09-29 Opekta-GmbH & Co., 5000 Köln Diaetetisches mittel, verfahren zu seiner herstellungund seine verwendung zur regulierung des cholesterinspiegels im serum
US5008254A (en) 1982-09-03 1991-04-16 Weibel Michael K Sugar beet pectins and their use in comestibles
US4533674A (en) 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
US4605666A (en) 1983-10-24 1986-08-12 Basf Corporation Process for preparing spray-dried powders containing a water-soluble vitamin and powders prepared thereby
FR2622198B1 (fr) * 1987-10-21 1992-04-30 Mero Rousselot Satia Compositions granulees de polysaccharides a dissolution aqueuse instantanee, procede pour leur preparation et utilisation
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
RU2008015C1 (ru) * 1992-04-10 1994-02-28 Нина Павловна Максютина Способ получения витаминного средства "витапектин"
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
DE19733094A1 (de) 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität
DE19744473A1 (de) 1997-10-09 1999-04-15 Basf Ag Verwendung von wasserlöslichen oder wasserdispergierbaren Polyurethanen als Überzugsmittel oder Bindemittel für pharmazeutische Darreichungsformen
US6060078A (en) 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6143337A (en) * 1999-04-30 2000-11-07 The United States Of America As Represented By The Secretary Of Agriculture Extraction of pectin by microwave heating under pressure
ATE250415T1 (de) * 1999-12-22 2003-10-15 Hoffmann La Roche Arzneizusammensetzung enthaltend ascorbinsäure und pektin

Also Published As

Publication number Publication date
EP1423109A2 (en) 2004-06-02
WO2003020265A3 (en) 2003-09-04
ATE307579T1 (de) 2005-11-15
CA2458209C (en) 2010-11-09
DE60206940D1 (de) 2005-12-01
WO2003020265A2 (en) 2003-03-13
BRPI0212195B1 (pt) 2018-02-14
DE60206940T2 (de) 2006-04-20
US20050008692A1 (en) 2005-01-13
US20090227536A1 (en) 2009-09-10
KR20040036927A (ko) 2004-05-03
EP1423109B1 (en) 2005-10-26
ES2250711T3 (es) 2006-04-16
US8242096B2 (en) 2012-08-14
BRPI0212195B8 (pt) 2021-05-25
KR100628603B1 (ko) 2006-09-26
BR0212195A (pt) 2004-10-05
JP2005502676A (ja) 2005-01-27
CN1549710A (zh) 2004-11-24
CN101653421A (zh) 2010-02-24
JP4339685B2 (ja) 2009-10-07
CA2458209A1 (en) 2003-03-13
MXPA04001768A (es) 2004-11-22

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
MXPA05005709A (es) Composiciones farmaceuticas que comprenden un compuesto farmacologico basico respectivamente acido, un agente tensioactivo y un acido hidrosoluble fisiologicamente tolerable respectivamente base.
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
NO2013019I1 (no) Kombinasjon omfattende aliskiren, som den frie basen eller som et farmasøytisk akseptabelt salt derav, og hydroklortiazid eller et farmasøytisk akseptabelt salt derav.
DE602004010493D1 (de) Kaugummi in der form von mehrschichttabletten
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
HUP0402566A3 (en) C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them
SE0102315D0 (sv) Compounds
HUP0402313A3 (en) Phenyl-piperazine derivatives as serotonin reuptake inhibitors, pharmaceutical compositions containing them and use thereof
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
PL356904A1 (en) Pharmaceutical compositions
ATE321537T1 (de) Pharmazeutische zubereitung enthaltend doxazosin
DK1161228T3 (da) Præparat omfattende isoquercetin og ascorbinsyre i en sustained release-form
NO20035035D0 (no) Citrasalt av 5,8,14-triazatetracyklo (10.3.1.0 opphöyet 2,11 .0 opphöyet 4,9) - heksadeca-2. (11), 3,5,7,9-pentaen og farmasöytiskesammensetninger derav
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
IL157540A0 (en) N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
DK1423109T3 (da) Præparater som omfatter pektin og ascorbinsyre
ATE235832T1 (de) Hartkaramellen mit verbesserter lagerstabilität
PL374761A1 (en) N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them
HUP0303593A3 (en) Biguanide derivatives, pharmaceutical compositions containing them and their use
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
DK1110550T4 (da) Præparat omfattende ascorbinsyre som hovedbestanddel og pektin
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839